Low lung function in young adult life is associated with early mortality

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 10, 2017, Pages 1399-1401

  Vasquez, Monica M ^a   Zhou, Muhan ^a   Hu, Chengcheng ^a   Martinez, Fernando D ^a   Guerra, Stefano ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACCIDENT; ADULT; AIRWAY OBSTRUCTION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART DISEASE; HOMICIDE; HUMAN; LETTER; LUNG FUNCTION; LUNG SURGERY; MALIGNANT NEOPLASM; MORTALITY; MORTALITY RISK; PRIORITY JOURNAL; SMOKING; SPIROMETRY; SUICIDE; YOUNG ADULT; CAUSE OF DEATH; COHORT ANALYSIS; FEMALE; LUNG; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; VITAL CAPACITY;

ADULT; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MORTALITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; VITAL CAPACITY; YOUNG ADULT;

EID: 85019861878     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201608-1561LE     Document Type: Letter

References (12)

1. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007;30:616-622.
2. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-1959.
3. Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011;66:49-54.
4. Godfrey MS, Jankowich MD. The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern. Chest 2016;149:238-251.
5. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010;65:499-504.
6. Baughman P, Marott JL, Lange P, Martin CJ, Shankar A, Petsonk EL, Hnizdo E. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol 2012;27:933-943.
7. Vasquez MM, Zhou M, Hu C, Martinez FD, Guerra S. Lung function in young adult life and mortality risk [abstract]. Am J Respir Crit Care Med 2015;191:A2315.
8. Lebowitz MD, Knudson RJ, Burrows B. Tucson epidemiologic study of obstructive lung diseases: I: methodology and prevalence of disease. Am J Epidemiol 1975;102:137-152.
9. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve: normal standards, variability, and effects of age. Am Rev Respir Dis 1976;113:587-600.
10. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734.
11. Parthasarathy S, Vasquez MM, Halonen M, Bootzin R, Quan SF, Martinez FD, Guerra S. Persistent insomnia is associated with mortality risk. Am J Med 2015;128:268-275.
12. Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015;373:111-122.